蒙特卡洛驱动的儿童脑肿瘤质子与光子放疗后神经认知及听力损伤预测
该研究基于50例接受光子调强放疗的儿童脑肿瘤患者现有放疗计划,生成质子调强放疗计划,利用蒙特卡洛模型和已发表的剂量-风险关系预测全量表智商(IQ)和每耳听力损失概率。与光子计划相比,质子计划在全脑平均剂量上降低,预期在放疗后5年使全队列IQ分别增加(54 Gy方案)和增加(59.4 Gy方案);每耳听力损失≥20 dB的概率在质子较光子更低:54 Gy方案为(9±4)%对(17±6)%,59.4 Gy方案为(13±5)%对(23±9)%。作者据此认为质子放疗预期可减轻儿童脑肿瘤放疗对IQ和听力的不良影响。
要点
- 质子计划较光子计划降低全脑平均剂量,预期在放疗后5年改善全队列IQ。
- 每耳听力损失≥20 dB概率:质子(9±4)% vs 光子(17±6)%(54 Gy方案)。
- 每耳听力损失≥20 dB概率:质子(13±5)% vs 光子(23±9)%(59.4 Gy方案)。
核心结论
- 作者认为,对于儿童脑肿瘤,质子放疗预期较光子放疗减轻放疗对IQ和听力的不良影响。
研究设计与样本
- 研究比较了50例接受光子调强放疗的儿童脑肿瘤患者的现有放疗计划与生成的质子调强放疗计划。
主要发现
- 与光子计划相比,所有质子计划的全脑平均剂量均降低。
- 全队列放疗后5年IQ增益:54 Gy方案增加(原文公式无法显示),59.4 Gy方案增加(原文公式无法显示),误差代表统计和系统不确定度。
- 每耳听力损失≥20 dB概率:质子(9±4)% vs 光子(17±6)%(54 Gy方案)。
- 每耳听力损失≥20 dB概率:质子(13±5)% vs 光子(23±9)%(59.4 Gy方案)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As proton radiotherapy (RT) remains a limited resource, predictive estimates of the potential reduction in adverse treatment-related outcomes compared to photon RT could potentially help improve treatment selection. The aim of this study was to predict the magnitude of the neurocognitive and hearing deficits associated with proton and photon RT for children with brain tumors. The existing RT plans for 50 children treated with photon intensity modulated RT were compared with generated intensity modulated proton RT plans. The proton and photon RT dose distribution was used to estimate the Full Scale Intelligence Quotient (IQ) via a Monte Carlo model and the probability of hearing loss per ear, based on previously published dose-risk relationships. Compared to photon plans, the mean brain dose was found to be reduced in all proton plans, translating into a gain of [Formula: see text] IQ points for the whole cohort at 5 years post-RT for dose regimens of 54 Gy, or [Formula: see text] IQ points for dose regimens of 59.4 Gy, where the errors shown represent statistical and systematic uncertainties. The probability of hearing loss ≥20 dB per ear was less for proton versus photon RT: overall (9 ± 4) versus (17 ± 6)%, respectively, based on dose regimens of 54 Gy, and (13 ± 5) versus (23 ± 9)% for dose regimens of 59.4 Gy. Proton RT is thus expected to reduce the detrimental effect of RT upon IQ and hearing as compared to photon RT for pediatric brain tumors.
引用
- Fortin D, Tsang D, Ng A, et al. Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients. J Neurooncol. 2017. PMID: 28825228. doi:10.1007/s11060-017-2597-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。